Xilio Therapeutics, Inc. (XLO)
9.00
+0.09
(+1.01%)
USD |
NASDAQ |
Sep 09, 13:07
Xilio Therapeutics Market Cap : 59.22M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 58.63M |
| September 04, 2026 | 59.22M |
| September 03, 2026 | 59.35M |
| September 02, 2026 | 58.17M |
| September 01, 2026 | 58.43M |
| August 31, 2026 | 58.89M |
| August 28, 2026 | 59.22M |
| August 27, 2026 | 59.29M |
| August 26, 2026 | 59.55M |
| August 25, 2026 | 59.75M |
| August 24, 2026 | 60.47M |
| August 21, 2026 | 60.73M |
| August 20, 2026 | 60.73M |
| August 19, 2026 | 61.92M |
| August 18, 2026 | 62.51M |
| August 17, 2026 | 62.45M |
| August 14, 2026 | 60.34M |
| August 13, 2026 | 59.29M |
| August 12, 2026 | 59.55M |
| August 11, 2026 | 60.41M |
| August 10, 2026 | 60.54M |
| August 07, 2026 | 60.34M |
| August 06, 2026 | 53.60M |
| August 05, 2026 | 52.68M |
| August 04, 2026 | 52.56M |
| Date | Value |
|---|---|
| August 03, 2026 | 52.33M |
| July 31, 2026 | 52.68M |
| July 30, 2026 | 52.51M |
| July 29, 2026 | 52.62M |
| July 28, 2026 | 52.91M |
| July 27, 2026 | 52.56M |
| July 24, 2026 | 50.02M |
| July 23, 2026 | 48.05M |
| July 22, 2026 | 49.04M |
| July 21, 2026 | 50.31M |
| July 20, 2026 | 49.56M |
| July 17, 2026 | 51.35M |
| July 16, 2026 | 52.22M |
| July 15, 2026 | 52.74M |
| July 14, 2026 | 52.22M |
| July 13, 2026 | 53.43M |
| July 10, 2026 | 52.62M |
| July 09, 2026 | 53.20M |
| July 08, 2026 | 53.66M |
| July 07, 2026 | 53.84M |
| July 06, 2026 | 54.59M |
| July 02, 2026 | 52.91M |
| July 01, 2026 | 53.31M |
| June 30, 2026 | 55.40M |
| June 29, 2026 | 53.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cue Biopharma, Inc. | 163.68M |
| ACADIA Pharmaceuticals, Inc. | 4.785B |
| Alnylam Pharmaceuticals, Inc. | 34.14B |
| Anika Therapeutics, Inc. | 279.97M |
| Savara, Inc. | 1.108B |
Market Cap Related Metrics
| PS Ratio | 2.067 |
| Price to Book Value | 0.8195 |
| Price | 9.00 |
| Earnings Yield | -18.73% |